Investment Watch is a quarterly publication delivering insights into equity strategy and economic trends. The Winter 2026 edition explores how the global economy enters Q3 2026 with the Iran conflict re-escalating, a reminder that the road to resolution is rarely straight. Markets have absorbed the renewed uncertainty better than many feared, reflecting the underlying resilience we have been backing all year.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy.

This edition arrives with the Iran conflict re-escalating, yet markets have absorbed the renewed uncertainty better than many feared. That resilience is why we stay the course. We see a strong second half for growth assets, powered by artificial intelligence, energy security and a global earnings cycle that keeps delivering.

The watchpoint is inflation. It is proving stickier than hoped, keeping interest rates higher for longer and rewarding investors who focus on income over speculation. We are optimistic, but clear eyed. The best returns in the second half will go to those who stay invested, stay diversified, and resist the temptation to sit on the sidelines.


Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Find out more
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Delve into three stocks undervalued after 2023's turbulence: Lovisa, ResMed, and Treasury Wine Estates.
Find out more
Research
Morgans Chief Economist Michael Knox discusses the key drivers for the lack of a US recession in 2023 and explains why Joe Biden's economic policy isn't more popular.
Find out more
Economics and markets
January 30, 2026
23
November
2023
2023-11-23
min read
Nov 23, 2023
Medibank AGM & APRA Insights
Richard Coles (AR: 001007378)
Richard Coles (AR: 001007378)
Senior Analyst
Key takeaways from Medibank's AGM and APRA statistics, highlighting financial performance and regulatory insights.
Find out more
Research
January 30, 2026
23
November
2023
2023-11-23
min read
Nov 23, 2023
Webjet: COVID in the Rear-View Mirror
Belinda Moore (AR: 000259141)
Belinda Moore (AR: 000259141)
Senior Analyst
Explore Webjet's (ASX:WEB) robust 1H24 report and optimistic outlook despite recent challenges.
Find out more
Research
January 30, 2026
22
November
2023
2023-11-22
min read
Nov 22, 2023
Technology One: Supercharging ARR
Nick Harris (AR: 000304090)
Nick Harris (AR: 000304090)
Senior Analyst
Technology One's (ASX:TNE) result was slightly better than expected with revenue momentum being the highlight.
Find out more
Research
February 3, 2026
22
November
2023
2023-11-22
min read
Nov 22, 2023
Brickworks: Long-Term Value Despite Headwinds
Liam Schofield (AR: 001296525)
Liam Schofield (AR: 001296525)
Analyst
Analysis of Brickworks' strategies to maintain long-term value while addressing current market challenges.
Find out more
Research
No results found.